| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 500 | 2017 |
| Gene correction for SCID-X1 in long-term hematopoietic stem cells M Pavel-Dinu, V Wiebking, BT Dejene, W Srifa, S Mantri, CE Nicolas, ... Nature communications 10 (1), 1634, 2019 | 212 | 2019 |
| Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing A Hendel, EJ Kildebeck, EJ Fine, JT Clark, N Punjya, V Sebastiano, ... Cell reports 7 (1), 293-305, 2014 | 146 | 2014 |
| Functional significance of U2AF1 S34F mutations in lung adenocarcinomas MS Esfahani, LJ Lee, YJ Jeon, RA Flynn, H Stehr, AB Hui, N Ishisoko, ... Nature Communications 10 (1), 5712, 2019 | 37 | 2019 |
| Artificial intelligence extension of the OSCAR‐IB criteria A Petzold, P Albrecht, L Balcer, E Bekkers, AU Brandt, PA Calabresi, ... Annals of clinical and translational neurology 8 (7), 1528-1542, 2021 | 36 | 2021 |
| An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer D Bu, G Tomlinson, CM Lewis, C Zhang, E Kildebeck, DM Euhus Breast cancer research and treatment 99, 257-265, 2006 | 36 | 2006 |
| Retinal architecture and melanopsin-mediated pupillary response characteristics: a putative pathophysiologic signature for the retino-hypothalamic tract in multiple sclerosis E Meltzer, PV Sguigna, A Subei, S Beh, E Kildebeck, D Conger, A Conger, ... JAMA neurology 74 (5), 574-582, 2017 | 33 | 2017 |
| CRISPR/Cas9 genome engineering in engraftable human brain-derived neural stem cells DP Dever, SG Scharenberg, J Camarena, EJ Kildebeck, JT Clark, ... Iscience 15, 524-535, 2019 | 32 | 2019 |
| Expanding the repertoire of target sites for zinc finger nuclease-mediated genome modification KA Wilson, AE McEwen, SM Pruett-Miller, J Zhang, EJ Kildebeck, ... Molecular Therapy-Nucleic Acids 2, 2013 | 29 | 2013 |
| High-dose methotrexate with leucovorin rescue: for monumentally severe CNS inflammatory syndromes SC Beh, E Kildebeck, R Narayan, A Desena, D Schell, ES Rowe, V Rowe, ... Journal of the neurological sciences 372, 187-195, 2017 | 18 | 2017 |
| Gene therapy for primary immunodeficiencies E Kildebeck, J Checketts, M Porteus Current opinion in pediatrics 24 (6), 731-738, 2012 | 18 | 2012 |
| Neurotherapeutic strategies for multiple sclerosis TC Frohman, SC Beh, EJ Kildebeck, R Narayan, K Treadaway, ... Neurologic Clinics 34 (3), 483-523, 2016 | 16 | 2016 |
| Toward defining a domain complexity measure across domains K Doctor, C Task, E Kildebeck, M Kejriwal, L Holder, R Leong arXiv preprint arXiv:2303.04141, 2023 | 13 | 2023 |
| Polycraft world ai lab (pal): An extensible platform for evaluating artificial intelligence agents SA Goss, RJ Steininger, D Narayanan, DV Olivença, Y Sun, P Qiu, ... arXiv preprint arXiv:2301.11891, 2023 | 8 | 2023 |
| Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon MJ Sobhanian, R Agarwal, E Meltzer, E Kildebeck, BS Frohman, ... Journal of the neurological sciences 387, 60-69, 2018 | 8 | 2018 |
| A neurosymbolic cognitive architecture framework for handling novelties in open worlds S Goel, P Lymperopoulos, R Thielstrom, E Krause, P Feeney, P Lorang, ... Artificial Intelligence 331, 104111, 2024 | 2 | 2024 |
| The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’T. Johnson EJ Kildebeck, R Narayan, A Nath, H Weiner, S Beh, PA Calabresi, ... Journal of neurology 264, 817-828, 2017 | 2 | 2017 |
| A Framework for Characterizing Novel Environment Transformations in General Environments M Molineaux, D Dannenhauer, E Kildebeck arXiv preprint arXiv:2305.04315, 2023 | 1 | 2023 |
| A Comparison of Repair Pathway Choice between ZFNs, TALENs, and CRISPRs at Endogenous Loci via Simultaneous Measurement of NHEJ and HDR Using SMRT Sequencing EJ Fine, A Hendel, EJ Kildebeck, CM Appleton, GC Washington, J Clark, ... Molecular Therapy 22, S34-S34, 2014 | 1 | 2014 |
| On-Target Cleavage and Off-Target Activity of TALEN'Nickases' TJ Cradick, CJ Antico, EJ Fine, CR Lindsay, E Kildebeck, DB Roth, ... MOLECULAR THERAPY 21, S125-S125, 2013 | 1 | 2013 |
